By James Eliot, Markets & Finance Editor
Last updated: June 19, 2026

Hospitals Slash Drug Costs by 90%: A Game-Changer in Healthcare

Hospitals have discovered a way to drastically reduce drug costs—by as much as 90%—through the repurposing of existing medications. This emerging trend is not simply about slashing expenses; it represents a fundamental challenge to the traditional power dynamics of the pharmaceutical industry. With cost-efficient alternatives gaining traction, hospitals and universities are setting a new standard for medication access, and in the process, redefining how we think about treatment and healthcare innovation.

A recent report from Kings College London illustrates that repurposed drugs can provide significant financial relief, costing 90% less than newly developed medications. The implications are profound, particularly as drug prices continue to climb. This shift allows healthcare systems to allocate resources more efficiently while ensuring patients receive essential treatments at a fraction of the typical cost.

What Is Drug Repurposing?

Drug repurposing—also known as drug repositioning—involves taking existing medications and finding new therapeutic uses for them. This strategy is noteworthy not only for its cost-effectiveness but also for its potential to expedite patient care by circumventing the lengthy and expensive traditional drug development process.

For healthcare professionals and investors alike, understanding drug repurposing matters significantly as it opens new avenues for treatment while mitigating the impact of soaring pharmaceutical prices. Think of it like taking an old smartphone and unlocking capabilities it originally didn’t have, enhancing its utility without the need for new production lines.

How Drug Repurposing Works in Practice

1. Kings College London’s Approach: At the forefront of repurposing initiatives, Kings College London has demonstrated that existing drugs can be adapted for new indications with remarkable efficiency. Their research indicates that hospitals can provide repurposed drugs at a cost that is up to 90% lower than the expenditure for developing new treatments. This cost reduction enables hospitals to treat more patients without straining budgets.

2. University of California Trials: At the University of California, researchers have been testing repurposed drugs for rare conditions that lack effective treatments. The results have been promising, leading to expedited approval processes and quicker access for patients. With traditional drug trials often taking over a decade, this method not only speeds up access to vital treatments but also provides substantial cost savings for healthcare systems.

3. FDA Approvals and Recognition: In 2022, the FDA approved a repurposed drug for a novel indication, marking a significant trend where hospitals increasingly explore off-label uses of existing medications. This regulatory shift not only supports the use of repurposed drugs but also creates a pathway for more innovative treatments to reach patients rapidly.

4. Pushback Against Big Pharma: Pharmaceuticals like Pfizer have faced intense scrutiny for rising drug prices. This criticism has catalyzed universities and healthcare institutions to ramp up their drug repurposing research. By providing solutions that are effective and affordable, these institutions challenge the monopolistic hold of big pharma over medication pricing.

A 2023 FDA Annual Report substantiates this trend, revealing that up to 25% of new drug approvals stem from existing therapies, further emphasizing the growing relevance of drug repurposing in addressing healthcare needs efficiently.

Top Tools and Solutions

For healthcare professionals looking to streamline the implementation of drug repurposing strategies, consider these tools:

Marketing Boost — Done-for-you vacation incentives and marketing tools to boost sales conversions and customer loyalty.
Livestorm — Video engagement platform for webinars and meetings.
Survicate — Customer feedback and survey platform.
Close CRM — Sales CRM built for high-velocity sales teams.
Instapage — Create high-converting landing pages fast using AI-powered page builder.
Increff — Inventory and warehouse management platform.

Common Mistakes and What to Avoid

1. Neglecting Comprehensive Clinical Trials: A hospital utilizing a repurposed drug without thorough evidence-based research risks patient safety. For instance, when a small clinic prematurely marketed a repurposed therapy for cancer treatment without adequate trials, it faced backlash for compromising patient trust and safety.

2. Ignoring Regulatory Guidance: Failing to adhere to FDA guidelines can lead to legal and financial repercussions. A notable example includes a university that launched a repurposed drug study without proper clearance, only to see its research halted and funding revoked.

3. Underestimating Market Needs: Misjudging the demand for specific repurposed drugs can lead to wasted resources. A case in point is a research group that invested heavily in repurposing a niche antidepressant without assessing patient needs, resulting in underwhelming utilization and financial loss.

Where This Is Heading

The trend of drug repurposing is expected to gain further momentum. Analysts predict that by 2025, the reliance on repurposed drugs could increase significantly as healthcare costs continue to rise. According to Goldman Sachs Research, the adoption of this strategy is likely to reshape market access for essential medications, empowering healthcare institutions to prioritize cost-effective solutions.

Within the next year, expect significant partnerships between universities and hospitals as they strive to innovate faster responses to healthcare crises such as the ongoing challenges posed by emerging diseases. Investors should pay attention to these collaborative efforts, as they will likely yield long-term benefits and redefine how patients access treatments.

FAQ

Q: What is drug repurposing?
A: Drug repurposing involves taking existing medications and finding new therapeutic uses for them. This strategy is crucial for reducing costs and expediting patient access to treatments.

Q: How does drug repurposing work?
A: Drug repurposing involves researching existing medications and assessing their effectiveness for new conditions, often requiring less time and investment than developing new drugs from scratch.

Q: How does drug repurposing compare to traditional drug development?
A: Drug repurposing is generally faster and less costly than traditional drug development, which can take over a decade. Existing drugs already have established safety profiles, reducing the time needed for trials.

Q: What is the typical cost of drug repurposing?
A: Drug repurposing can result in savings of up to 90% compared to the cost of developing new medications, according to Kings College London.

Q: What are common mistakes in drug repurposing?
A: Common mistakes include neglecting comprehensive clinical trials, ignoring regulatory guidelines, and underestimating market needs for repurposed drugs.

Q: How can hospitals successfully implement drug repurposing?
A: Hospitals can successfully implement drug repurposing by conducting thorough clinical research, collaborating with regulatory bodies, and aligning with market demands.

Q: What is the future trend of drug repurposing in healthcare?
A: The future trend indicates an increasing reliance on drug repurposing as a strategic approach to managing healthcare costs and improving patient access to medications.

Q: What is the best resource for drug repurposing strategies?
A: An excellent resource for staying updated on drug repurposing strategies is ongoing research publications and industry reports from reputable institutions such as Kings College London and the FDA.